drugset
drugset / Trial / NCT00773110

Study of Albumin to Reduce Inflammation Following Surgery

NCT00773110 ↗

Phase 2 Terminated 232 enrolled Imperial College London
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether albumin administration during cardiac surgery is effective in attenuating the development of inflammation following surgery.

Timeline

Start
2008-12
Primary completion
2011-05
Completion
2011-05

Outcome

Outcome not reported

Stopped (Enrollment): “Recruitment under target, Finding”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gelofusine Other / unclassified 300 ml Other
Subject Human Serum Albumin Protein / enzyme biologic 300 ml —

Indications

autoinflammatory syndrome